A new national “unit” is being established, with its own “chief executive”, to oversee innovation and medicines, the Department of Health and Social Care has announced.
Three pharmaceutical companies – including one which took NHS England to court over the design of a billion-pound tender – have been awarded contracts to supply drugs as part of a bid to eradicate hepatitis C by 2025.
Clinical commissioning groups could face renewed pressure to fund an expensive thyroid drug under NHS England revised guidance, due to be published shortly.
Patient groups have called NHS England “unbelievably arrogant” for failing to listen to patients during drug funding reviews.
NHS suppliers have been told to contact a new 24/7 call centre run by the Department of Health and Social Care if they experience disruption to their deliveries following a no-deal Brexit.
Councils in London are seeking additional funding from NHS England to help deal with cost pressures arising from trials for an HIV drug.
The number of generic drugs being sold above national tariff rose to its highest rate in over two years at the start of 2019, despite national efforts to cut this number.
Regulators and policymakers are at a loss for how to stop people accessing dangerous medicines using online services overseas, the outgoing chief inspector of GPs has said.
The Department of Health and Social Care has set up a “logistics hub” in Belgium and plans to manage its own dedicated shipping route from mainland Europe to the UK for vital medical products, as part of no-deal preparations, HSJ can reveal.
Hospitals have warned that a no deal Brexit could put their pharmacies at increased risk of burglary, as concerns about drug shortages mount.
NHS England will conduct a “rolling tour” of NHS providers to ensure everyone is “geared up” for a possible no-deal Brexit.
A major teaching hospital is putting plans in place to prioritise which patients to treat if a no-deal Brexit causes critical shortages in drugs and/or medical devices.
NHS England has seen off a legal challenge to its largest ever medicines procurement, which is aimed at acquiring drugs to help eliminate hepatitis C in the country by 2025.
The third largest London borough will discontinue its NHS-provided stop smoking service to save money.
Health minister Lord O’Shaughnessy has resigned from his post as Parliamentary under secretary of state in the House of Lords for family reasons.
The prices of certain generic drugs are “seeing another surge” which could have a significant impact on the finances of NHS commissioners, a pharmacy body has warned.
Multiple clinical commissioning groups have raised concerns that patients will start stockpiling medicines and costs will rise if a Brexit deal is not confirmed soon.
A former Department of Health and Social Care permanent secretary has called on the government to put more emphasis on an “innovation rich and technology rich NHS” in order to maintain “a really vibrant life sciences industry” post Brexit.
The government has negotiated a new deal with the pharmaceutical industry which raises the NHS’ cap on spending on branded medicines.
NHS trusts must report annually on how they have dealt with staff concerns over patient safety, under new legislation proposed by the Department of Health and Social Care.
The chief executive of the UK’s medicine regulator is to leave his post in September 2019, six months after the UK is due to leave the European Union.
NHS providers could be asked to stockpile certain types of products under government plans to mitigate the UK leaving the EU without an agreed deal.
A global pharmaceutical company has taken the NHS to court over a procurement process aimed to help England become the first country to eliminate hepatitis C.
Ministers have launched a tender worth “tens of millions” of pounds to provide extra storage capacity in the event of the UK crashing out of the EU without a deal.
NHS providers must submit a business case to show setting up a wholly owned subsidiary company yields value beyond VAT savings, under new proposals from NHS Improvement.
Hundreds of tonnes of human body parts and dangerous waste from NHS patients has been stockpiled by a leading disposal company, sparking a major national incident.
The price of generic drugs could be forced up in the case of a no-deal Brexit, HSJ understands from senior industry sources.
The NHS has today won a landmark legal battle against two international pharmaceutical giants which could save the health service hundreds of millions of pounds a year.
An HSJ roundtable, sponsored by BD, looked at how to reduce medication errors, improving outcomes for patients and reducing waste from unused or unnecessary medicines.
Pharmaceutical industry leaders have warned the government needs to be “fleet of foot” to avoid a significant cost if a no-deal Brexit disrupts approval of generic and biosimilar medicines.